Mutares enters its annual general meeting in Munich on Thursday with two significant overhangs lifted — the BaFin has closed its examination of the 2023 financial statements without major findings, and the company has successfully passed a critical bond covenant deadline that had hung over the balance sheet since last year. The dual all-clear removes immediate regulatory and credit risk, yet the stock remains under pressure, edging down 1.39% to €28.40 as investors weigh the lack of a performance-linked dividend.
The BaFin probe, originally launched to check for potential accounting violations, ended with a mild verdict. The regulator identified only one missing disclosure in the notes — the residual maturity of internal receivables — which Mutares has already amended for future periods. The management report passed without objection. Separately, the bond covenant test that triggered creditor scrutiny after a breach last year has now been satisfied, with the deadline passing just ahead of the shareholder meeting. The double clearance provides breathing room but has not fully restored market confidence, given the stock has lost nearly 18% over the past twelve months and sits 18% below its 52-week high of €35.15.
On the dividend front, the board is proposing a base payout of €2.00 per share, unchanged from last year. That figure is widely seen as a floor, with any additional performance component explicitly tied to future portfolio exits. For now, shareholders get the base distribution only, and the absence of a bonus payout underscores the urgency for the management to accelerate disposals in the second half of the year.
Operationally, Mutares is moving to strengthen its existing portfolio. The group’s plastics specialist LMS is being expanded through Amaneos, which is acquiring Magna’s European automotive lighting business. The deal adds approximately €200 million in annual revenue and brings in about 1,500 employees across four sites, injecting new LED technology capabilities. The acquisition builds on a string of recent bolt-on moves aimed at deepening the value of current holdings.
Should investors sell immediately? Or is it worth buying Mutares?
A more transformative deal is already inked. Mutares has signed the sale of the NEM Energy Group to Hyundai Heavy Industries, with completion scheduled for the third quarter of 2026. That transaction — once closed — will demonstrate the underlying earnings power of the portfolio and provide a concrete benchmark for the promised exit wave. In the near term, the market is also watching the strategic review of Magirus, where options include a potential initial public offering. No final decision has been announced.
The group’s financial targets for the current year remain ambitious. Revenue is forecast to reach between €7.9 billion and €9.1 billion, while net income is expected to come in at €165 million or higher. Meeting those numbers depends heavily on timely asset sales. Without a steady stream of disposal proceeds, the performance dividend remains hypothetical, and the debt burden moves back into focus.
Technically, the stock is sending faint recovery signals. The share price is trading about 4% above its short-term trendline, and the widely watched 50-day moving average sits at €27.41, offering a near-term support floor. The 200-day moving average at €28.91 stands as an immediate resistance level, and the current indecisive price action — oscillating around the moving averages — reflects the market’s wait-and-see stance.
Until Mutares provides concrete timelines for its exit pipeline, the shares are likely to drift sideways. The next major catalyst will be the half-year report due in the third quarter, which will offer the first hard data on whether the ambitious revenue and profit goals remain within reach. If disposals materialise as promised, the stock should find a firmer footing. If not, the focus will shift squarely back to the balance sheet and the ability to sustain both dividends and debt reduction simultaneously.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from July 3 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 3.
Mutares: Buy or sell? Read more here...
